Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on November 7, 2019, covering an event reported on November 5, 2019. The Company is a Delaware corporation listed on The Nasdaq Stock Market LLC under the symbol "GH" and is classified as an emerging growth company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director. On November 5, 2019, Aaref Hilaly notified the Board of Directors of his resignation, effective November 6, 2019. The Company explicitly stated that the resignation was not the result of any dispute or disagreement regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on future performance, or specific risk factors. The only commentary provided confirms the amicable nature of the director's departure.
Key Facts for Investor Verification
- Director Aaref Hilaly resigned effective November 6, 2019.
- The resignation was not caused by any disagreement with the Company.
- The report was signed by Helmy Eltoukhy, Chief Executive Officer.
- No financial results or operational metrics are included in this specific filing.